|
|
Blood, 1 April 2008, Vol. 111, No. 7, pp. 3863-3866.
Prepublished online as a Blood First Edition Paper on January 14, 2008; DOI 10.1182/blood-2007-09-111971.
Previous Article | Table of Contents | Next Article 
NEOPLASIA
Brief Report
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
Sai Li1,
Robert Kralovics2,
Gennaro De Libero3,
Alexandre Theocharides4,
Heinz Gisslinger2, and
Radek C. Skoda1
1 Department of Research, Experimental Hematology, University Hospital Basel, Basel, Switzerland;
2 Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, and the Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria;
3 Department of Research, Experimental Immunology and
4 Division of Hematology, University Hospital Basel, Basel, Switzerland
We studied the lineage distribution of JAK2 mutations in peripheral blood of 8 polycythemia vera (PV) patients with exon 12 mutations and in 21 PV patients with JAK2-V617F. Using a quantitative allele discrimination assay, we detected exon 12 mutations in purified granulocytes, monocytes, and platelets of 8 patients studied, but lymphoid cells showed variable involvement and the mutation was absent in T cells. Endogenous erythroid colonies grew in all patients analyzed. One patient displayed erythroid colonies homozygous for the exon 12 mutation with evidence for mitotic recombination on chromosome 9p. In some patients with exon 12 mutations or JAK2-V617F, a proportion of endogenous erythroid colonies were negative for both JAK2 mutations. One patient carried 2 independent clones: one with an exon 12 mutation and a second with JAK2-V617F. The finding of clonal heterogeneity is compatible with the hypothesis that additional clonal events are involved in the pathogenesis of PV.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. H. Ohyashiki, H. Hisatomi, S. Shimizu, M. Sugaya, and K. Ohyashiki
Detection of Low Allele Burden of JAK2 Exon 12 Mutations Using TA-cloning in Patients with Erythrocytosis
Jpn. J. Clin. Oncol.,
June 2, 2009;
(2009)
hyp048v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schnittger, U. Bacher, C. Haferlach, T. Geer, P. Muller, J. Mittermuller, P. Petrides, R. Schlag, R. Sandner, J. Selbach, et al.
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
Haematologica,
March 1, 2009;
94(3):
414 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. X. Schaub, R. Jager, R. Looser, H. Hao-Shen, S. Hermouet, F. Girodon, A. Tichelli, H. Gisslinger, R. Kralovics, and R. C. Skoda
Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F
Blood,
February 26, 2009;
113(9):
2022 - 2027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Theocharides, J. R. Passweg, M. Medinger, R. Looser, S. Li, H. Hao-Shen, A. S. Buser, A. Gratwohl, A. Tichelli, and R. C. Skoda
The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders
Haematologica,
December 1, 2008;
93(12):
1890 - 1893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Jones, N. C.P. Cross, H. E. White, A. R. Green, and L. M. Scott
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis
Haematologica,
October 1, 2008;
93(10):
1560 - 1564.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|